Research institute
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 26, 2020.
Interactive data rapidly available on state, region or county level
New research out of the Memorial Sloan Kettering Cancer Center suggests the genetically engineered immune cells can be used to treat diseases of senescence, which could include fibrotic liver disease, atherosclerosis, and diabetes.
A study published in the Journal of Experimental Medicine on Monday revealed new research that showed pancreatic cancer metastasis may be suppressible by inhibiting a protein that regulates cell movement.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
UCLA Jonsson Comprehensive Cancer Center researchers and their colleagues announced on May 1 that they have discovered a drug that may help improve the overall survival rate in glioblastoma patients.
The Bill & Melinda Gates Foundation supports international collaboration to expand global access to life-saving vaccines
With emergency approval, the Oxford University researchers believe they could have a few million doses of the vaccine available by September if it is proven effective.
Two specific cell types in the nose have been identified as likely initial infection points for COVID-19 coronavirus.
PRESS RELEASES